Home » Authors » Kim Coghill

Articles by Kim Coghill

Push For Public Posting Of Clinical Trial Data Continues

Sep. 10, 2004

Push For Public Posting Of Clinical Trial Data Continues

Sep. 10, 2004

Encysive Brings In $30.8M, Presents Thelin Data At ERS

Sep. 9, 2004

Encysive Brings In $30.8M, Presents Thelin Data At ERS

Sep. 9, 2004

States Angling To Control Reimportation, Stem Cells

Sep. 7, 2004

States Angling To Control Reimportation, Stem Cells

Sep. 7, 2004

Achillion Gets $10.4M As Part Of Series D, Names New CEO

Sep. 3, 2004

Achillion Pharmaceuticals Inc. on Thursday closed a $10.4 million financing and announced the appointment of Michael Kishbauch as president and CEO. (BioWorld Today)

Achillion Gets $10.4M As Part Of Series D, Names New CEO

Sep. 3, 2004

Achillion Pharmaceuticals Inc. on Thursday closed a $10.4 million financing and announced the appointment of Michael Kishbauch as president and CEO. (BioWorld Today)

MDS Paying Applied Biosystems $40M For MALDI Product Line IP

Sep. 2, 2004

MDS Paying Applied Biosystems $40M For MALDI Product Line IP

Sep. 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...